Chakrabarti, S <br/><br/>
Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.  [electronic resource] 

 -  Bone marrow transplantation  Oct 2001 
 - 759-63 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703216  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Anemia--chemically induced<br/>Anemia, Aplastic--therapy<br/>Antiviral Agents--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Graft vs Host Disease--complications<br/>Hematologic Neoplasms--therapy<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunocompromised Host<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Parainfluenza Virus 3, Human--drug effects<br/>Pilot Projects<br/>Pneumonia, Viral--drug therapy<br/>Population Surveillance<br/>Prospective Studies<br/>Respiratory Syncytial Virus Infections--drug therapy<br/>Respirovirus Infections--drug therapy<br/>Ribavirin--administration & dosage<br/>Transplantation Conditioning--adverse effects<br/>Treatment Outcome